Osteoradionecrosis of the skull base.


Journal

Journal of neuro-oncology
ISSN: 1573-7373
Titre abrégé: J Neurooncol
Pays: United States
ID NLM: 8309335

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 25 10 2019
accepted: 18 03 2020
pubmed: 13 5 2020
medline: 5 10 2021
entrez: 13 5 2020
Statut: ppublish

Résumé

Radiation therapy (RT) is often necessary for the treatment of head and neck cancers. Osteoradionecrosis (ORN) is a rare, but potentially serious complication of RT. RT leads to the destruction of vasculature in radiated tissue causing hypoxia and tissue necrosis. ORN can occur in any bone, but bones with naturally poor blood supply appear to be more susceptible. Bones of the skull base are susceptible, with ORN occurring in the anterior, central, and lateral skull base. Risk factors include cancer type and location, radiation dose, and a variety of patient factors. Patients often present with pain, bleeding, and foul odor and are typically found to have exposed and necrotic bone. Treatment options vary depending on the severity, but typically include pentoxifylline and vitamin E as well as surgical debridement, with less evidence supporting hyperbaric oxygen therapy. Recognition and prompt treatment of ORN will allow for improved patient outcomes.

Identifiants

pubmed: 32394326
doi: 10.1007/s11060-020-03462-3
pii: 10.1007/s11060-020-03462-3
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

477-482

Références

Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7–34. https://doi.org/10.3322/caac.21551
doi: 10.3322/caac.21551 pubmed: 30620402
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492
doi: 10.3322/caac.21492 pubmed: 30207593
Marx RE (1983) Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg 41:283–288. https://doi.org/10.1016/0278-2391(83)90294-x
doi: 10.1016/0278-2391(83)90294-x pubmed: 6572704
Bras J, De Jonge HKT, Van Merkesteyn JPR (1990) Osteoradionecrosis of the mandible: pathogenesis. Am J Otolaryngol 11:244–250. https://doi.org/10.1016/0196-0709(90)90084-9
doi: 10.1016/0196-0709(90)90084-9 pubmed: 2240412
Chopra S, Kamdar D, Tulunay Ugur OE et al (2011) Factors predictive of severity of osteoradionecrosis of the mandible. Head Neck 33:1600–1605. https://doi.org/10.1002/hed.21654
doi: 10.1002/hed.21654 pubmed: 21484922
Reuther T, Schuster T, Mende U, Kübler A (2003) Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients—a report of a thirty year retrospective review. Int J Oral Maxillofac Surg 32:289–295. https://doi.org/10.1054/ijom.2002.0332
doi: 10.1054/ijom.2002.0332 pubmed: 12767877
Offiah C, Hall E (2011) Post-treatment imaging appearances in head and neck cancer patients. Clin Radiol 66:13–24. https://doi.org/10.1016/j.crad.2010.09.004
doi: 10.1016/j.crad.2010.09.004 pubmed: 21147294
Jang JW, Chan AW (2013) Prevention and management of complications after radiotherapy for skull base tumors: a multidisciplinary approach. Bleier BS (ed): Comprehensive techniques in CSF leak repair and skull base reconstruction. Adv Otorhinolaryngol Basel Karger 74:163–173. https://doi.org/10.1159/000342293
doi: 10.1159/000342293
Han P, Wang X, Liang F et al (2018) Osteoradionecrosis of the skull base in nasopharyngeal carcinoma: incidence and risk factors. Int J Radiat Oncol Biol Phys 102:552–555. https://doi.org/10.1016/j.ijrobp.2018.06.027
doi: 10.1016/j.ijrobp.2018.06.027 pubmed: 29960057
Morrissey D, Grigg R (2011) Incidence of osteoradionecrosis of the temporal bone. ANZ J Surg 81:876–879. https://doi.org/10.1111/j.1445-2197.2010.05641.x
doi: 10.1111/j.1445-2197.2010.05641.x pubmed: 22507412
Leonetti JP, Marzo SJ, Zender CA, Porter RG, Melian E (2010) Temporal bone osteoradionecrosis after surgery and radiotherapy for malignant parotid tumors. Otol Neurotol 31:656–659
doi: 10.1097/MAO.0b013e3181d8d6e1
NRG Oncology (2014) HN001: individualized treatment in treating patients with stage II-IVB nasopharyngeal cancer based on EBV DNA
Fu KK, Newman H, Phillips TL (1975) Treatment of locally recurrent carcinoma of the nasopharynx. Radiology 117:425–431. https://doi.org/10.1148/117.2.425
doi: 10.1148/117.2.425 pubmed: 170644
Duprez F, Madani I, Bonte K et al (2009) Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory. Radiother Oncol 93:563–569. https://doi.org/10.1016/j.radonc.2009.10.012
doi: 10.1016/j.radonc.2009.10.012 pubmed: 19919885
Blanchard P, Lee A, Marguet S et al (2015) Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol 16:645–655. https://doi.org/10.1016/S1470-2045(15)70126-9
doi: 10.1016/S1470-2045(15)70126-9 pubmed: 25957714
Wahl MJ (2006) Osteoradionecrosis prevention myths. Int J Radiat Oncol Biol Phys 64:661–669. https://doi.org/10.1016/j.ijrobp.2005.10.021
doi: 10.1016/j.ijrobp.2005.10.021 pubmed: 16458773
Sathasivam HP, Davies GR, Boyd NM (2018) Predictive factors for osteoradionecrosis of the jaws: a retrospective study. Head Neck 40:46–54. https://doi.org/10.1002/hed.24907
doi: 10.1002/hed.24907 pubmed: 29149496
Katsura K, Sasai K, Sato K, Saito M, Hoshina H, Hayashi T (2008) Relationship between oral health status and development of osteoradionecrosis of the mandible: a retrospective longitudinal study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:731–738. https://doi.org/10.1016/j.tripleo.2007.10.011
doi: 10.1016/j.tripleo.2007.10.011 pubmed: 18329913
Lyons AJ, West CM, Risk JM et al (2012) Osteoradionecrosis in head-and-neck cancer has a distinct genotype-dependent cause. Int J Radiat Oncol Biol Phys 82:1479–1484. https://doi.org/10.1016/j.ijrobp.2011.05.016
doi: 10.1016/j.ijrobp.2011.05.016 pubmed: 21708430
Jereczek-Fossa BA, Orecchia R (2002) Radiotherapy-induced mandibular bone complications. Cancer Treat Rev 28:65–74. https://doi.org/10.1053/ctrv.2002.0254
doi: 10.1053/ctrv.2002.0254 pubmed: 12027415
Hao SP, Chen HC, Wei FC, Chen CY, Yeh ARM, Su JL (1999) Systematic management of osteoradionecrosis in the head and neck. Laryngoscope 109:1324–1327. https://doi.org/10.1097/00005537-199908000-00027
doi: 10.1097/00005537-199908000-00027 pubmed: 10443843
Chang KP, Tsang NM, Chen CY, Su JL, Hao SP (2000) Endoscopic management of skull base osteoradionecrosis. Laryngoscope 110:1162–1165. https://doi.org/10.1097/00005537-200007000-00018
doi: 10.1097/00005537-200007000-00018 pubmed: 10892689
Huang XM, Zheng YQ, Zhang XM et al (2006) Diagnosis and management of skull base osteoradionecrosis after radiotherapy for nasopharyngeal carcinoma. Laryngoscope 116:1626–1631. https://doi.org/10.1097/01.mlg.0000230435.71328.b9
doi: 10.1097/01.mlg.0000230435.71328.b9 pubmed: 16954993
King AD, Ahuja AT, Yeung DK et al (2007) Delayed complications of radiotherapy treatment for nasopharyngeal carcinoma: imaging findings. Clin Radiol 62:195–203. https://doi.org/10.1016/j.crad.2006.10.011
doi: 10.1016/j.crad.2006.10.011 pubmed: 17293211
Hutchinson IL (1996) Complications of radiotherapy in the head and neck: an orofacial surgeon’s view. In: Current radiation oncology. Arnold, London, pp 144–177
Alhilali L, Reynolds AR, Fakhran S (2014) Osteoradionecrosis after radiation therapy for head and neck cancer: differentiation from recurrent disease with CT and PET/CT imaging. Am J Neuroradiol 35:1405–1411. https://doi.org/10.3174/ajnr.A3879
doi: 10.3174/ajnr.A3879 pubmed: 24627451
Peterson DE, Doerr W, Hovan A et al (2010) Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies. Support Care Cancer 18:1089–1098. https://doi.org/10.1007/s00520-010-0898-6
doi: 10.1007/s00520-010-0898-6 pubmed: 20526784
Niezgoda JA, Serena TE, Carter MJ (2016) Outcomes of radiation injuries using hyperbaric oxygen therapy: an observational cohort study. Adv Skin Wound Care 29:12–19. https://doi.org/10.1097/01.ASW.0000473679.29537.c0
doi: 10.1097/01.ASW.0000473679.29537.c0 pubmed: 26650092
Annane D, Depondt J, Aubert P, Villart M, Géhanno P, Gajdos P, Chevret S (2004) Hyperbaric oxygen therapy for radionecrosis of the jaw: a randomized, placebo-controlled, double-blind trial from the ORN 96 study group. J Clin Oncol 22:4893–4900. https://doi.org/10.1200/JCO.2004.09.006
doi: 10.1200/JCO.2004.09.006 pubmed: 15520052
Delanian S, Depondt J, Lefaix JL (2005) Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial. Head Neck J Sci Spec Head Neck 27:114–123. https://doi.org/10.1002/hed.20121
doi: 10.1002/hed.20121
Delanian S, Chatel C, Porcher R, Depondt J, Lefaix JL (2011) Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline–tocopherol–clodronate combination (PENTOCLO): a phase II trial. Int J Radiat Oncol Biol Phys 80:832–839. https://doi.org/10.1016/j.ijrobp.2010.03.029
doi: 10.1016/j.ijrobp.2010.03.029 pubmed: 20638190
Huang WB, Wong STS, Chan JYW (2018) Role of surgery in the treatment of osteoradionecrosis and its complications after radiotherapy for nasopharyngeal carcinoma. Head Neck 40:369–376. https://doi.org/10.1002/hed.24973
doi: 10.1002/hed.24973 pubmed: 28990255
Chan YW, Chow VLY, Wei WI (2012) Quality of life of patients after salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma. Cancer 118:3710–3718. https://doi.org/10.1002/cncr.26719
doi: 10.1002/cncr.26719 pubmed: 22180127
Wu CT, Lee ST (1999) Delayed spontaneous tension pneumocephalus caused by radionecrosis of the skull base. Br J Neurosurg 13:214–216. https://doi.org/10.1080/02688699944032
doi: 10.1080/02688699944032 pubmed: 10616596
Kwong Lam HC, Abdullah VJ, Wormald PJ, Van Hasselt CA (2001) Internal carotid artery hemorrhage after irradiation and osteoradionecrosis of the skull base. Otolaryngol Head Neck Surg 125:522–527. https://doi.org/10.1067/mhn.2001.118248
doi: 10.1067/mhn.2001.118248
Park CW, Jin BJ, Jeong SW, Min HJ, Shin JH, Lee SH (2009) CSF otorrhea resulting from osteoradionecrosis of the temporal bone in a patient with recurrent meningioma. Clin Exp Otorhinolaryngol 2:97. https://doi.org/10.3342/ceo.2009.2.2.97
doi: 10.3342/ceo.2009.2.2.97 pubmed: 19565035 pmcid: 2702734

Auteurs

John P Leonetti (JP)

Department of Otolaryngology, Head and Neck Surgery, The Loyola Center for Cranial Base Tumors, Loyola University of Chicago, 2160 S. 1st Ave, Maywood, IL, 60153, USA. jleonet@lumc.edu.

Jeffrey R Weishaar (JR)

Department of Otolaryngology, Head and Neck Surgery, The Loyola Center for Cranial Base Tumors, Loyola University of Chicago, 2160 S. 1st Ave, Maywood, IL, 60153, USA.

David Gannon (D)

Loyola Stritch School of Medicine, The Loyola Center for Cranial Base Tumors, Loyola University of Chicago, 2160 S. 1st Ave, Maywood, IL, 60153, USA.

Grant A Harmon (GA)

Department of Radiation Oncology, The Loyola Center for Cranial Base Tumors, Loyola University of Chicago, 2160 S. 1st Ave, Maywood, IL, 60153, USA.

Alec Block (A)

Department of Radiation Oncology, The Loyola Center for Cranial Base Tumors, Loyola University of Chicago, 2160 S. 1st Ave, Maywood, IL, 60153, USA.

Douglas E Anderson (DE)

Department of Neurological Surgery, The Loyola Center for Cranial Base Tumors, Loyola University of Chicago, 2160 S. 1st Ave, Maywood, IL, 60153, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH